Feasibility of continued treatment with dupilumab in patients with type 2 inflammatory disease who developed eosinophilic pneumonia: 3 case reports

Documenti analoghi

• Efficacy of dupilumab as an alternative to corticosteroids in the treatment of exacerbations of allergic bronchopulmonary aspergillosis
  di: Masamitsu Hamakawa, et al.
  Pubblicazione: (2024)
• Benralizumab‐resistant mucus plugs in severe asthma complicated by eosinophilic chronic rhinosinusitis
  di: Masamitsu Hamakawa, et al.
  Pubblicazione: (2024)
• A case of allergic bronchopulmonary mycosis: 3D‐CT Findings led to successful multidisciplinary treatment with dupilumab and cryoprobe
  di: Masamitsu Hamakawa, et al.
  Pubblicazione: (2024)
• Imaging in pleural amyloidosis: A diagnostic challenge
  di: Masamitsu Hamakawa, et al.
  Pubblicazione: (2024)
• Allergic bronchopulmonary mycosis in Schizophyllum commune with positive Aspergillus‐specific IgE antibodies: A case report
  di: Hiroshi Takahashi, et al.
  Pubblicazione: (2024)